Financhill
Sell
40

PNRG Quote, Financials, Valuation and Earnings

Last price:
$187.60
Seasonality move :
3.53%
Day range:
$175.38 - $189.25
52-week range:
$126.40 - $238.20
Dividend yield:
0%
P/E ratio:
17.98x
P/S ratio:
2.28x
P/B ratio:
1.44x
Volume:
70K
Avg. volume:
55.1K
1-year change:
-4.38%
Market cap:
$307.4M
Revenue:
$233.9M
EPS (TTM):
$10.46
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $52.4M $82.4M $93.3M $123.1M $233.9M
Revenue Growth (YoY) -51.88% 57.17% 13.17% 32.01% 89.97%
 
Cost of Revenues $60.2M $59.9M $77M $82.4M $146.2M
Gross Profit -$7.8M $22.5M $16.3M $40.7M $87.7M
Gross Profit Margin -14.82% 27.33% 17.47% 33.07% 37.5%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $15M $9.1M $20.2M $15.6M $18.9M
Other Inc / (Exp) $15.8M $3.2M $19.8M $9.3M $3.7M
Operating Expenses $15M $9.1M $20.2M $15.6M $18.9M
Operating Income -$22.8M $13.4M -$3.9M $25.1M $68.8M
 
Net Interest Expenses $1.9M $2M $909K $535K $1.5M
EBT. Incl. Unusual Items -$2.9M $4.6M $59M $34.2M $71.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$517K $2.5M $10.3M $6.1M $15.8M
Net Income to Company -$2.4M $2.1M $48.7M $28.1M $55.4M
 
Minority Interest in Earnings -$47K $28K -- -- --
Net Income to Common Excl Extra Items -$2.4M $2.1M $48.7M $28.1M $55.4M
 
Basic EPS (Cont. Ops) -$1.16 $1.05 $24.91 $15.19 $31.43
Diluted EPS (Cont. Ops) -$1.16 $0.76 $17.95 $10.77 $21.95
Weighted Average Basic Share $2M $2M $2M $1.8M $1.8M
Weighted Average Diluted Share $2M $2.7M $2.7M $2.6M $2.5M
 
EBITDA $5.4M $39.8M $24.1M $56.7M $146M
EBIT -$22.8M $13.4M -$3.9M $25.1M $68.8M
 
Revenue (Reported) $52.4M $82.4M $93.3M $123.1M $233.9M
Operating Income (Reported) -$22.8M $13.4M -$3.9M $25.1M $68.8M
Operating Income (Adjusted) -$22.8M $13.4M -$3.9M $25.1M $68.8M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $20.5M $37.5M $35.4M $66.7M $44.7M
Revenue Growth (YoY) 62.95% 82.91% -5.64% 88.53% -33%
 
Cost of Revenues $16.2M $19.1M $21.6M $37M $29.2M
Gross Profit $4.3M $18.4M $13.7M $29.6M $15.5M
Gross Profit Margin 20.91% 49.09% 38.87% 44.45% 34.74%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $2M $2.5M $2.7M $3.9M $3M
Other Inc / (Exp) $5K $494K $2.1M $2.8M --
Operating Expenses $2M $2.5M $2.7M $3.9M $3M
Operating Income $2.3M $15.9M $11M $25.7M $12.5M
 
Net Interest Expenses $462K $253K $133K $414K $482K
EBT. Incl. Unusual Items -$1.3M $18M $13.1M $28.1M $13.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$186K $4.9M $2.4M $6M $2.7M
Net Income to Company -$1.1M $13.2M $10.7M $22.1M $10.6M
 
Minority Interest in Earnings $15K -- -- -- --
Net Income to Common Excl Extra Items -$1.1M $13.2M $10.7M $22.1M $10.6M
 
Basic EPS (Cont. Ops) -$0.58 $6.79 $5.84 $12.63 $6.41
Diluted EPS (Cont. Ops) -$0.58 $4.88 $4.13 $8.80 $4.38
Weighted Average Basic Share $2M $1.9M $1.8M $1.7M $1.6M
Weighted Average Diluted Share $2M $2.7M $2.6M $2.5M $2.4M
 
EBITDA $9.2M $23.7M $20.1M $44.1M $26.7M
EBIT $2.3M $15.9M $11M $25.7M $12.5M
 
Revenue (Reported) $20.5M $37.5M $35.4M $66.7M $44.7M
Operating Income (Reported) $2.3M $15.9M $11M $25.7M $12.5M
Operating Income (Adjusted) $2.3M $15.9M $11M $25.7M $12.5M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $65.7M $142.9M $110.7M $208.6M $196.1M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $53.3M $75.7M $78.5M $121.3M $146.2M
Gross Profit $12.4M $67.2M $32.2M $87.3M $49.9M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $8.3M $14.4M $16.8M $18.4M $16.9M
Other Inc / (Exp) $982K $18.4M $13M $4.1M --
Operating Expenses $8.3M $14.4M $16.8M $18.4M $16.9M
Operating Income $4.1M $52.7M $15.4M $68.9M $32.9M
 
Net Interest Expenses $1.7M $1.3M $585K $972K $2.5M
EBT. Incl. Unusual Items -$6.9M $57.9M $40.5M $73.3M $32.9M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $447K $15.5M $4.9M $14.3M $7.7M
Net Income to Company -$7.3M $42.4M $35.6M $59M $25.2M
 
Minority Interest in Earnings $68K $24K -- -- --
Net Income to Common Excl Extra Items -$7.3M $42.4M $35.6M $59M $25.2M
 
Basic EPS (Cont. Ops) -$3.71 $21.55 $18.90 $33.21 $15.08
Diluted EPS (Cont. Ops) -$3.71 $16.26 $13.47 $24.21 $10.46
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $27.7M $81M $44.9M $123.5M $119.5M
EBIT $4.1M $52.7M $15.4M $68.9M $32.9M
 
Revenue (Reported) $65.7M $142.9M $110.7M $208.6M $196.1M
Operating Income (Reported) $4.1M $52.7M $15.4M $68.9M $32.9M
Operating Income (Adjusted) $4.1M $52.7M $15.4M $68.9M $32.9M
Period Ending 2022-09-30 2023-09-30 2024-09-30 2025-09-30 2026-09-30
Revenue $112.8M $87.2M $173.7M $135.8M --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $57.3M $59.6M $98.5M $98.5M --
Gross Profit $55.5M $27.6M $75.2M $37.4M --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $11.5M $8.1M $10.9M $8.9M --
Other Inc / (Exp) $15.3M $8.6M $3.4M $619K --
Operating Expenses $11.5M $8.1M $10.9M $8.9M --
Operating Income $44M $19.5M $64.4M $28.5M --
 
Net Interest Expenses $752K $428K $865K $1.8M --
EBT. Incl. Unusual Items $46.5M $28M $67.1M $28.9M --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $11.2M $5.8M $14M $5.9M --
Net Income to Company $35.3M $22.2M $53.1M $22.9M --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $35.3M $22.2M $53.1M $22.9M --
 
Basic EPS (Cont. Ops) $17.98 $11.94 $29.98 $13.75 --
Diluted EPS (Cont. Ops) $12.97 $8.48 $20.98 $9.43 --
Weighted Average Basic Share $5.9M $5.6M $5.3M $5M --
Weighted Average Diluted Share $8.2M $7.9M $7.6M $7.3M --
 
EBITDA $65.9M $42.9M $110.7M $84.2M --
EBIT $44M $19.5M $64.4M $28.5M --
 
Revenue (Reported) $112.8M $87.2M $173.7M $135.8M --
Operating Income (Reported) $44M $19.5M $64.4M $28.5M --
Operating Income (Adjusted) $44M $19.5M $64.4M $28.5M --
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $996K $10.3M $26.5M $11.1M $2.5M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $3.9M $12.2M $10.3M $16.1M $21.8M
Inventory -- -- -- -- --
Prepaid Expenses $590K $733K $32.8M $376K $1.4M
Other Current Assets $104K $40K $38K $38K $11K
Total Current Assets $8.9M $25.3M $72.2M $31.8M $28.3M
 
Property Plant And Equipment $191.1M $184.7M $174M $256.1M $295.8M
Long-Term Investments $97K -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- $923K $985K $673K $515K
Total Assets $200.5M $212.9M $248.2M $289.5M $325.3M
 
Accounts Payable $876K $2.4M $5.1M $9.8M $12M
Accrued Expenses $2.4M $3M $6.7M $33.5M $8.6M
Current Portion Of Long-Term Debt $487K -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- $3.9M $4.3M
Other Current Liabilities $724K $4.9M $1.2M -- --
Total Current Liabilities $14.1M $21.7M $41M $64.8M $49.7M
 
Long-Term Debt $38.3M $36M $11.2M $38K $4M
Capital Leases -- -- -- -- --
Total Liabilities $102.5M $113.8M $107.8M $128.5M $122.4M
 
Common Stock $281K $281K $281K $281K $281K
Other Common Equity Adj -- -- -- -- --
Common Equity $97.1M $99.1M $140.4M $161M $202.9M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $874K -- -- -- --
Total Equity $98M $99.1M $140.4M $161M $202.9M
 
Total Liabilities and Equity $200.5M $212.9M $248.2M $289.5M $325.3M
Cash and Short Terms $996K $10.3M $26.5M $11.1M $2.5M
Total Debt $38.8M $36M $11.2M $38K $4M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Cash and Equivalents $3.6M $24.1M $19.8M $1.6M $3.7M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $11.4M $14.5M $15.4M $29.4M $16.6M
Inventory -- -- -- -- --
Prepaid Expenses $781K $783K $413K $1.1M $1.2M
Other Current Assets $568K $348K $38K $5K --
Total Current Assets $19.3M $42.1M $37.6M $37M $24M
 
Property Plant And Equipment $182.3M $170M $215.6M $307.9M $307M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $593K -- $403K $703K --
Total Assets $202.2M $212.9M $253.6M $345.6M $332M
 
Accounts Payable $7M $1.4M $7.2M $36.6M $22.9M
Accrued Expenses $2.8M $3.1M $20.6M $7.5M --
Current Portion Of Long-Term Debt $1.4M -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- $4.5M --
Other Current Liabilities $6.2M $4M -- -- --
Total Current Liabilities $26.7M $22.2M $41.7M $68M $45.3M
 
Long-Term Debt $32.5M -- $77K $3M $163K
Capital Leases -- -- -- -- --
Total Liabilities $109.2M $83.5M $97.6M $141.8M $118.2M
 
Common Stock $281K $281K $281K $281K $281K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $853K -- -- -- --
Total Equity $93M $129.4M $156M $203.8M $213.8M
 
Total Liabilities and Equity $202.2M $212.9M $253.6M $345.6M $332M
Cash and Short Terms $3.6M $24.1M $19.8M $1.6M $3.7M
Total Debt $33.8M -- $77K $3M $163K
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$2.4M $2.1M $48.7M $28.1M $55.4M
Depreciation & Amoritzation $28.2M $26.3M $28.1M $31.7M $77.2M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $7.1M -$6.9M $1.7M -$8.1M -$3.8M
Change in Inventories -- -- -- -- --
Cash From Operations $16.4M $28.6M $33.1M $109M $115.9M
 
Capital Expenditures $10.5M $20.7M $16M $113.8M $119.2M
Cash Acquisitions $742K $676K -- -- --
Cash From Investing -$403K -$19.9M $15.5M -$105.7M -$115M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $6.8M $11.2M $11M -- $110.5M
Long-Term Debt Repaid -$22M -$10.2M -$36M -$11.3M -$106.5M
Repurchase of Common Stock $710K $145K $7.4M $7.5M $13.4M
Other Financing Activities -$799K -$873K -- -- --
Cash From Financing -$16M $658K -$32.4M -$18.8M -$9.4M
 
Beginning Cash (CF) $996K $10.3M $26.5M $11.1M $2.5M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$19K $9.4M $16.2M -$15.5M -$8.5M
Ending Cash (CF) $977K $19.7M $42.7M -$4.4M -$6M
 
Levered Free Cash Flow $5.9M $7.9M $17.2M -$4.8M -$3.3M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders -$1.1M $13.2M $10.7M $22.1M $10.6M
Depreciation & Amoritzation $6.9M $7.7M $9.1M $18.4M $14.3M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$4.1M $708K $9.8M $11.2M $9.8M
Change in Inventories -- -- -- -- --
Cash From Operations $7.4M $19.9M $35.3M $39.6M $54.7M
 
Capital Expenditures $7.6M $5.6M $20.1M $42M $39.3M
Cash Acquisitions $6K -- -- -- --
Cash From Investing -$7.6M -$5.1M -$19.1M -$38.5M -$39.3M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -$4M $27M --
Long-Term Debt Repaid -- -- $3.7M -$24M --
Repurchase of Common Stock -- $1.8M $1.2M $4.5M $2M
Other Financing Activities -$6K -- -- -- --
Cash From Financing -- -$1.8M -$1.5M -$1.5M -$14M
 
Beginning Cash (CF) $3.6M $24.1M $19.8M $1.6M $3.7M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$173K $13M $14.7M -$433K $1.3M
Ending Cash (CF) $3.5M $37.1M $34.5M $1.1M $5M
 
Levered Free Cash Flow -$172K $14.3M $15.2M -$2.4M $15.4M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders -$7.3M $42.4M $35.6M $59M $25.2M
Depreciation & Amoritzation $23.6M $28.3M $29.5M $54.6M $86.6M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$9.1M -$2.6M -$429K -$17.3M $15.5M
Change in Inventories -- -- -- -- --
Cash From Operations $17.3M $57.1M $56.5M $130.3M $108.4M
 
Capital Expenditures $8.7M $17.4M $75.1M $145.1M $88.8M
Cash Acquisitions $748K $670K -- -- --
Cash From Investing -$9.2M -$1.4M -$51.5M -$140.3M -$88.1M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $3M -- $11M $57.5M --
Long-Term Debt Repaid -$11.5M -$38.2M -$11.3M -$54.5M --
Repurchase of Common Stock $1K $5.1M $9M $11.2M $15.3M
Other Financing Activities -- -- -- -- --
Cash From Financing -$8.5M -$35.3M -$9.3M -$8.2M -$18.3M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$462K $20.4M -$4.3M -$18.2M $2.1M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $8.6M $39.7M -$18.6M -$14.8M $19.6M
Period Ending 2022-09-30 2023-09-30 2024-09-30 2025-09-30 2026-09-30
Net Income to Stockholders $35.3M $22.2M $53.1M $22.9M --
Depreciation & Amoritzation $21.9M $23.4M $46.4M $55.7M --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$2.7M -$4.8M -$14M $5.2M --
Change in Inventories -- -- -- -- --
Cash From Operations $47.3M $70.7M $92M $84.5M --
 
Capital Expenditures $8M $67.1M $98.4M $68M --
Cash Acquisitions -- -- -- -- --
Cash From Investing $7.4M -$59.6M -$94.2M -$67.3M --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- $57.5M $24M --
Long-Term Debt Repaid -$36M -$11.3M -$54.5M -$21.5M --
Repurchase of Common Stock $5M $6.6M $10.2M $12.1M --
Other Financing Activities -- -- -- -- --
Cash From Financing -$41M -$17.8M -$7.2M -$16.1M --
 
Beginning Cash (CF) $39.2M $38.6M $5.3M $8.2M --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $13.7M -$6.8M -$9.5M $1.1M --
Ending Cash (CF) $52.9M $31.8M -$4.1M $9.3M --
 
Levered Free Cash Flow $39.4M $3.7M -$6.4M $16.6M --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Sell
50
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 35x

Sell
40
Is GOOGL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 29x

Alerts

Buy
77
RNG alert for Feb 23

RingCentral, Inc. [RNG] is down 11.67% over the past day.

Sell
9
FROG alert for Feb 23

JFrog Ltd. [FROG] is down 5.75% over the past day.

Buy
72
SNSE alert for Feb 23

Sensei Biotherapeutics, Inc. [SNSE] is down 2.12% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock